Therapeutics Company Announces Positive Findings From Oxylanthanum Carbonate Clinical Trial
Unicycive Therapeutics Announces Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC).
Disclaimer: The information presented in this article is intended for informational purposes only and should not be construed as investment advice, medical advice, or an endorsement of any product or company. The details provided are based on the results of a clinical trial conducted by Unicycive Therapeutics, Inc. (Nasdaq: UNCY)…